Product and method for obtaining specific immunisation with one or more antigens
CA 2361353 A1 · Owner: Heeney, Jonathan Luke · Inventors: Heeney, Jonathan Luke
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A large number of recombinant of viral and bacterial systems has been engineered as vectors to express foreign genes for vaccination and/or gene therapy. A common problem is the immune response to the vector itself. The presence of anti-vector immune responses may preclude sufficient priming or delivery if pre-existing immune responses are present or impair optimal , "boosting" upon subsequent immunisation or delivery. The invention provides means and methods for vaccinating an animal or a human to obtain therein an immune response against at least one antigen comprising different vaccine , compositions for sequential administration to said animal or said human each , containing at …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 28, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 28, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 28, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.